OBJECTIVES Transcatheter aortic valve replacement (TAVR) represents a valid treatment
for patients with aortic valve stenosis and high or intermediate surgical risk. However …

Background Surgical aortic valve replacement and transcatheter aortic valve replacement
(TAVR) are now both used to treat aortic stenosis in patients in whom life expectancy may …

Aortic valve disorders are important considerations in advanced heart failure patients being
evaluated for left ventricular assist devices (LVAD) and those on LVAD support. Aortic …

Objectives This study sought to determine the degree of Evolut (Medtronic) leaflet pinning,
diameter expansion, leaflet overhang, and performance at different implant depths of the …

Background The long‐term clinical performance of transcatheter heart valves (THV) is
unknown. Aims This study assessed the clinical outcomes, rate of structural valve …

Background Transcatheter heart valve (THV) dysfunction with an elevated gradient or
paravalvular leak (PVL) may be documented late after THV implantation. Medical …

Congenital heart valve disease has life-threatening consequences that warrant early valve
replacement; however, the development of a growth-accommodating prosthetic valve has …

Background THV implantation within failed surgical valves is well established. However, the
implications of THV implantation within failed THVs are poorly understood. Aims This study …

Objectives This study assessed the long-term durability of nominally deployed transcatheter
heart valves (THV) to 1 billion cycles (equivalent to 25 years) and non-nominal …

Objectives The aim of this study was to report the 1-year results of transcatheter aortic valve
replacement (TAVR) with the Edwards SAPIEN 3 (S3) valve in extremely large annuli …